Source: International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Bush (London, United Kingdom). Montelukast in paediatric asthma: where we are now and what still needs to be done?. International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"

Member's Comments

No comment yet.

Related content which might interest you: What is new in paediatric asthma? Source: Annual Congress 2006 - Paediatric year in review Year: 2006 What’s new in paediatric asthma? Source: International Congress 2018 – Paediatric Year in Review Year: 2018 Is it more than just asthma? Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 Montelukast: better option in childhood asthma and boon for associated tonsillitis Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Adherence to asthma treatment: Can it be improved in general practice? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 What is COPD? What is asthma? Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 How is difficult asthma managed? Source: Eur Respir J 2006; 28: 968-973 Year: 2006 Managing asthma in the outpatient clinic: Is the diagnosis of asthma confirmed objectively according to guidelines? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 Microbiomics and paediatric asthma Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016 Breathomics and paediatric asthma Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma Year: 2016 Paediatric asthma: where to go? Source: Eur Respir Rev 2012 21:173-174 Year: 2012 Paediatric asthma: where to go? Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine Year: 2013 The burden of paediatric asthma: economic and familiar Source: Eur Respir Mon 2012; 56: 71-81 Year: 2012 An update on paediatric asthma Source: Eur Respir Rev 2012 21:175-185 Year: 2012 Montelukast for toddler asthma? A meta-analysis of montelukast in preschool wheeze Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016